Brand name
Trijardy XR, the original
We didn’t find a savings card or cash price from Trijardy XR’s maker. Ask the pharmacy for Trijardy XR’s cash price. With insurance, ask what your plan charges.
Generic name: empagliflozin, linagliptin, and metformin
Used for: Type 2 diabetes · Lowering the risk of heart-related death in type 2 diabetes · 1 more
Cash price
$330+ for 30 tablets
Pharmacies pay about this for Trijardy XR; you’d pay more.
No generic is sold yet.
Trijardy XR, the original
We didn’t find a savings card or cash price from Trijardy XR’s maker. Ask the pharmacy for Trijardy XR’s cash price. With insurance, ask what your plan charges.
There isn’t one.
No generic is sold yet.
TRIJARDY XR is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Empagliflozin is indicated to reduce the risk of cardiovascular (CV) death in adults with type 2 diabetes mellitus and established CV disease.
Limitations of Use
Source: the FDA label for Trijardy XR (Boehringer Ingelheim Pharmaceuticals, Inc.), August 24, 2026. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/trijardy-xr/